Abstract:IMPORTANCE There is conflicting evidence on the association between intrapartum epidural analgesia and risk of autism spectrum disorder (ASD) in offspring.OBJECTIVE To evaluate the association between intrapartum epidural analgesia and the risk of ASD in offspring.
DESIGN, SETTING, AND PARTICIPANTS This population-based cohort study was conducted inOntario, Canada, using the health and administrative records of singleton live births by vaginal delivery between April 1, 2006, and March 31, 2014. Neonates with … Show more
“…The results from the study by Murphy and colleagues 4 are timely and important because they replicate the negligible association measure between intrapartum epidural analgesia and ASD in a population with a possibly different confounding structure than in previous research. 6 As shown by Straub and colleagues, 6 the pooled hazard ratio for ASD across recent studies conducted in the US, Denmark, and Canadian provinces other than Ontario was negligible (10% increased hazard).…”
mentioning
confidence: 64%
“…Validation of outcome status is also crucial in establishing whether an exposure is associated with a particular outcome. In their work, Murphy and colleagues defined ASD as the presence of at least 1 relevant diagnosis code at hospital discharge, emergency department visit, or outpatient surgery or at least 3 diagnostic codes within the health insurance plan records. Furthermore, the authors applied an alternative ASD outcome definition to maximize the outcome specificity.…”
mentioning
confidence: 71%
“…The study by Murphy and colleagues used region-wide administrative health care data in Ontario, Canada, to investigate the association between intrapartum epidural analgesia and risk for ASD. The study identified 650 373 mothers with singleton live births delivered vaginally between 2006 and 2014.…”
mentioning
confidence: 99%
“…Despite its weaknesses and limitations, the collective body of evidence from epidemiologic studies supports the notion that there is no meaningful association between intrapartum epidural analgesia for vaginal delivery and ASD in offspring. This latest research by Murphy and colleagues consolidates this conclusion and provides additional reassurance to pregnant patients and health care practitioners.…”
“…The results from the study by Murphy and colleagues 4 are timely and important because they replicate the negligible association measure between intrapartum epidural analgesia and ASD in a population with a possibly different confounding structure than in previous research. 6 As shown by Straub and colleagues, 6 the pooled hazard ratio for ASD across recent studies conducted in the US, Denmark, and Canadian provinces other than Ontario was negligible (10% increased hazard).…”
mentioning
confidence: 64%
“…Validation of outcome status is also crucial in establishing whether an exposure is associated with a particular outcome. In their work, Murphy and colleagues defined ASD as the presence of at least 1 relevant diagnosis code at hospital discharge, emergency department visit, or outpatient surgery or at least 3 diagnostic codes within the health insurance plan records. Furthermore, the authors applied an alternative ASD outcome definition to maximize the outcome specificity.…”
mentioning
confidence: 71%
“…The study by Murphy and colleagues used region-wide administrative health care data in Ontario, Canada, to investigate the association between intrapartum epidural analgesia and risk for ASD. The study identified 650 373 mothers with singleton live births delivered vaginally between 2006 and 2014.…”
mentioning
confidence: 99%
“…Despite its weaknesses and limitations, the collective body of evidence from epidemiologic studies supports the notion that there is no meaningful association between intrapartum epidural analgesia for vaginal delivery and ASD in offspring. This latest research by Murphy and colleagues consolidates this conclusion and provides additional reassurance to pregnant patients and health care practitioners.…”
“…Recent observational studies have suggested that LNA may alter physiological functions in the developing brain and potentially lead to autism spectrum disorders. 3,4 Although the association between LNA and long-term neurodevelopmental disability remains controversial, 5,6 it is important to understand the potential effects of LNA on neonatal neurophysiological functions. May clinicians would agree that it is rational to predict long-term consequence from the short-term status.…”
Aim
This single‐center observational study aimed to investigate the association between labor neuraxial analgesia (LNA) and neonatal outcomes.
Methods
We conducted a retrospective cohort study at a tertiary perinatal center and included all vaginal deliveries performed between November 2015 and December 2021. Obstetric and neonatal outcomes were compared between deliveries with LNA (LNA group) and without analgesia (control group). Propensity score (PS) matching was used for statistical analysis.
Results
We included 2343 singleton deliveries performed in 1367 nulliparous and 976 multiparous women, in whom LNA was induced in 352 and 178 deliveries, respectively. After PS matching, the nulliparous LNA group had a significantly higher incidence of Apgar scores <7 at 1 (7.1% vs. 3.6%, p = 0.0139) and 5 min (2.3% vs. 0.7%, p = 0.0397) and meconium staining (29.8% vs. 23.2%, p = 0.0272) than the nulliparous control group. Other neonatal outcomes, including umbilical artery pH and neonatal intensive care unit admission rate, were comparable between the nulliparous LNA and control groups. No significant differences in neonatal outcomes were seen in multiparous women. Regarding fetal heart rate abnormalities, severe late deceleration (4.8% vs. 1.7%, p = 0.0036) and severe prolonged deceleration (17.0% vs. 11.9%, p = 0.0224) were more common in the nulliparous LNA group than in the nulliparous control group, and the multiparous LNA group exhibited more severe variable deceleration (21.3% vs. 14.3%, p = 0.0485) than the multiparous control group.
Conclusion
Our findings suggest that LNA is associated with short‐term adverse neonatal and obstetric outcomes in vaginal deliveries. LNA should be performed with precautionary measures and adequate medical resources.
ImportanceMaternal labor epidural analgesia (LEA) and oxytocin use for labor and delivery have been reported to be associated with child autism spectrum disorders (ASD). However, it remains unclear whether these 2 common medications used during labor and delivery have synergistic associations with ASD risk in children.ObjectiveTo assess the independent associations of LEA and oxytocin during labor and delivery with ASD, as well as outcome modification associated with the concurrent use of both interventions.Design, Setting, and ParticipantsData for this cohort study included 205 994 singleton births with vaginal deliveries in a single integrated health care system in Southern California from calendar years 2008 to 2017. Children were followed up to December 31, 2021. Data on use of LEA and oxytocin, covariates, and ASD outcome in children were obtained from electronic medical records. Cox proportional hazards regression was used to estimate the hazard ratios (HRs) adjusting for covariates.ExposuresLabor epidural analgesia and/or oxytocin use during labor and delivery.Main Outcomes and MeasuresA child’s clinical diagnosis of ASD during follow-up and at age of diagnosis.ResultsAmong the cohort, 153 880 children (74.7%) were exposed to maternal LEA and 117 808 children (57.2%) were exposed to oxytocin during labor and delivery. The population of children was approximately half boys and half girls. The median (IQR) age of the mothers was 30.8 (26.8-34.5) years for those not exposed to LEA, 30.0 (25.9-33.8) years for those exposed to LEA, 30.4 (26.5-34.1) years for those unexposed to oxytocin, and 30.0 (25.9-33.9) years for those exposed to oxytocin during labor and delivery. A total of 5146 children (2.5%) had ASD diagnosed during follow-up. Oxytocin exposure was higher among LEA-exposed (67.7%) than -unexposed (26.1%) children. The ASD risk associated with LEA was independent of oxytocin exposure (HR, 1.28; 95% CI, 1.18-1.38); however, the ASD risk associated with oxytocin was not significant after adjusting for LEA exposure (HR, 1.05; 95% CI, 0.99-1.12). A significant interaction of LEA and oxytocin on child ASD risk was found (P = .02 for interaction). Compared with no exposure, HRs were 1.20 (95% CI, 1.09-1.32) for LEA alone, 1.30 (95% CI, 1.20-1.42) for both LEA and oxytocin, and 0.90 (95% CI, 0.78-1.04) for oxytocin alone.Conclusions and RelevanceThe findings of this cohort study suggest an association between maternal LEA and ASD risk in children, and the risk appeared to be further increased if oxytocin was also administered. Oxytocin exposure without LEA exposure was not associated with ASD risk in children. These findings must be interpreted with caution. Further studies are needed to replicate or refute the study results and examine biological plausibility.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.